ResMed Inc. Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year Three
ResMed Inc. (RMD) had Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year Three of $2.06 million as of 2022-06-30, per its 10-K filed 2022-08-12.
Discontinued › Notes › Leases › Sales-Type and Direct Financing Leases, Payment to be Received, Fiscal Year Maturity
us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears · last filed 2022-08-12
- 2022-06-30: Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year Three $2.06M.
- 2021-06-30: Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year Three $1.70M.
- 2020-06-30: Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year Three $2.28M.
| Period end | Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year Three |
|---|---|
| 2022-06-30 | $2.06M 10-K · filed 2022-08-12 |
| 2021-06-30 | $1.70M 10-K · filed 2021-08-17 |
| 2020-06-30 | $2.28M 10-K · filed 2020-08-13 |